欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Brucella suis Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP535823BWU
CSB-EP535823BWU
CSB-BP535823BWU
CSB-MP535823BWU
CSB-EP535823BWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella suis NADH-quinone oxidoreductase subunit I (nuoI) CSB-YP535824BWU
CSB-EP535824BWU
CSB-BP535824BWU
CSB-MP535824BWU
CSB-EP535824BWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella suis Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (cobT) CSB-YP535825BWU
CSB-EP535825BWU
CSB-BP535825BWU
CSB-MP535825BWU
CSB-EP535825BWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio V-set and immunoglobulin domain-containing protein 10 (vsig10), partial CSB-YP535826DIL
CSB-EP535826DIL
CSB-BP535826DIL
CSB-MP535826DIL
CSB-EP535826DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Laccaria bicolor Elongation factor Ts, mitochondrial (TSF1) CSB-YP535827LLZ
CSB-EP535827LLZ
CSB-BP535827LLZ
CSB-MP535827LLZ
CSB-EP535827LLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Laccaria bicolor Plasma membrane fusion protein PRM1 (PRM1), partial CSB-YP535828LLZ
CSB-EP535828LLZ
CSB-BP535828LLZ
CSB-MP535828LLZ
CSB-EP535828LLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Laccaria bicolor Protein GET1 (GET1), partial CSB-YP535829LLZ1
CSB-EP535829LLZ1
CSB-BP535829LLZ1
CSB-MP535829LLZ1
CSB-EP535829LLZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Laccaria bicolor Altered inheritance of mitochondria protein 31, mitochondrial (AIM31), partial CSB-YP535830LLZ1
CSB-EP535830LLZ1
CSB-BP535830LLZ1
CSB-MP535830LLZ1
CSB-EP535830LLZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Laccaria bicolor 3-ketoacyl-CoA reductase (LACBIDRAFT_192627), partial CSB-YP535831LLZ1
CSB-EP535831LLZ1
CSB-BP535831LLZ1
CSB-MP535831LLZ1
CSB-EP535831LLZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Laccaria bicolor Mitochondrial distribution and morphology protein 12 (MDM12) CSB-YP535832LLZ
CSB-EP535832LLZ
CSB-BP535832LLZ
CSB-MP535832LLZ
CSB-EP535832LLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Laccaria bicolor Ribosome biogenesis protein YTM1 (YTM1) CSB-YP535833LLZ
CSB-EP535833LLZ
CSB-BP535833LLZ
CSB-MP535833LLZ
CSB-EP535833LLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Entamoeba dispar ATPase ASNA1 homolog (EDI_044870) CSB-YP535834EKL
CSB-EP535834EKL
CSB-BP535834EKL
CSB-MP535834EKL
CSB-EP535834EKL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Manduca sexta MD-2-related lipid-recognition protein CSB-YP535835MPV
CSB-EP535835MPV
CSB-BP535835MPV
CSB-MP535835MPV
CSB-EP535835MPV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Myb-like protein AA (mybAA), partial CSB-YP535836DKK
CSB-EP535836DKK
CSB-BP535836DKK
CSB-MP535836DKK
CSB-EP535836DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Mitochondrial substrate carrier family protein ucpB (ucpB) CSB-YP535837DKK
CSB-EP535837DKK
CSB-BP535837DKK
CSB-MP535837DKK
CSB-EP535837DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa DNA mismatch repair protein MutS (mutS), partial CSB-YP535838MTQ
CSB-EP535838MTQ
CSB-BP535838MTQ
CSB-MP535838MTQ
CSB-EP535838MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa N utilization substance protein B homolog (nusB) CSB-YP535839MTQ
CSB-EP535839MTQ
CSB-BP535839MTQ
CSB-MP535839MTQ
CSB-EP535839MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP535840MTQ
CSB-EP535840MTQ
CSB-BP535840MTQ
CSB-MP535840MTQ
CSB-EP535840MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Elongation factor P (efp) CSB-YP535841MTQ
CSB-EP535841MTQ
CSB-BP535841MTQ
CSB-MP535841MTQ
CSB-EP535841MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa 50S ribosomal protein L5 (rplE) CSB-YP535842MTQ
CSB-EP535842MTQ
CSB-BP535842MTQ
CSB-MP535842MTQ
CSB-EP535842MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×